Rheumatoid arthritis (RA) is a common systemic disease that manifests as inflammatory arthritis of multiple joints and produces a wide variety of intrathoracic lesions, including pleural diseases, diffuse interstitial pneumonia, rheumatoid nodules, and airway disease. Patients treated for RA can have associated lung disease that commonly manifests as diffuse interstitial pneumonia, drug-induced lung injury, and infection. The purpose of this pictorial review is to illustrate the radiographic and clinical features of lung complications of acute or subacute onset in patients treated for RA and to show the computed tomography features of these complications.
Lung complications of acute or subacute onset (within 3 months) in patients treated for rheumatoid arthritis (RA) are divided into 2 major categories: (1) lung complications of the RA itself [1, 2] and (2) those related to RA treatment, which include drug-induced lung injury (DLI) and infection. Because clinical and radiographic features of these lesions are similar, the correct diagnosis requires understanding of the combined features. In this article, we illustrate clinical and radiographic features of these conditions.
Lung Complications of RA Itself
Common acute or subacute lung complications of RA include organizing pneumonia (OP) and acute exacerbation (AE) of pre-existing chronic interstitial pneumonia (CIP). Acute interstitial pneumonia (AIP) without pre-existing CIP is rare in patients with RA.
OP OP is one of the most frequent lung complications of RA. Imaging features are multiple nonsegmental foci of consolidation, which show subpleural or peribronchovascular distribution [3] . Ground-glass opacity (GGO) may be present in the periphery of the consolidation. Traction bronchiectasis may be identified within the consolidation. Differential diagnosis includes bacterial pneumonia, cryptococcus pneumonia, and OP-like DLI (Figure 1 [OP]).
AE of CIP
AE of CIP may develop with RA; symptoms may rapidly progress within 1 month. In patients with RA, AE of CIP may occur with nonspecific interstitial pneumonia (NSIP) but less frequently than AE of CIP with the usual IP (UIP) pattern [2, 4] . Imaging features of AE are diffuse or multiple patchy areas of GGO that overlap the features of CIP.
Reticular opacity or honeycombing suggests fibrotic changes. Traction bronchiectasis and structural distortion are frequently seen as well. Comparison with previous images is useful for differentiation, and the presence of honeycomb lung suggests AE of CIP caused by AIP ( Figure 2 [AE of UIP in RA]).
Complications Related to RA Treatment
Common acute or subacute lung complications include DLI and infection. year-old man with pre-existing chronic interstitial pneumonia (CIP) who had been treated with MTX for 4 years. Computed tomography, showing bilateral heterogeneous ground-glass opacity that overlaps pre-existing interstitial pneumonia (IP) of usual (usual IP) pattern in the lower lobes. Traction bronchiectasis (arrow) is evident, which suggests diffuse alveolar damagelike pattern. Because this patient with CIP developed AE whose trigger was thought to be MTX, we diagnosed MTX-induced lung injury.
DLI
Although glucocorticoid and many disease-modifying antirheumatic drugs have been used to treat patients with RA, low-dose methotrexate (MTX) is the recent standard treatment [5] ; use of anticytokine biologic drugs, such as infliximab, etanercept, and tocilizumab, has also spread rapidly. Because autoimmune mechanisms play an important role in DLI, patients with RA seem more susceptible to DLI.
Clinical Features of DLI
Clinical signs and symptoms of DLI are nonspecific respiratory symptoms, such as dry cough and exertional dyspnea. There are no reliable noninvasive laboratory tests for diagnosing DLI. Accurate diagnosis requires integration of clinical, imaging, and laboratory findings, and includes observation of the temporal relationship between onset of signs and administration of suspicious drugs, the exclusion of infection, and the progression of complications of RA itself. One of the most important roles of imaging diagnosis in the evaluation of DLI is the detection of pre-existing CIP and other destructive diseases, which constitute one of the most important risk factors of DLI.
Imaging Features of DLI
Fundamental imaging features of DLI are patchy or diffuse GGO and/or consolidation that is occasionally accompanied by reticular opacity and interlobular septal thickening. Images of DLI have been classified by similarities to idiopathic forms of lung injury. Based on imaging features, patterns of DLI are classified as AIP-like, OP-like, hypersensitivity pneumonia (HP)-like, eosinophilic pneumonia-like, or NSIP-like pattern, or as unclassifiable [6] . However, because pathologic findings have not been fully evaluated, the application of such imaging classification of DLI is limited. Although DLI caused by a particular drug frequently demonstrates a specific pattern, DLI caused by a single drug may manifest with different pathologic and/or imaging patterns. On computed tomography (CT), the most frequent pattern of MTX-induced DLI is an HP-like pattern; diffuse or widespread patchy GGO that corresponds to pathologic findings of lymphocytic infiltration, with small 
Infection
The combination of MTX and anticytokine biologic drugs has become a standard therapeutic regimen for RA, but it induces immunodeficiency that may cause opportunistic infection, one of the most serious and frequent complications. In patients with RA, bacterial pneumonia is the most frequent infection, but tuberculosis, fungal infection, Pneumocystis jiroveci pneumonia (PcP), and other pneumonia may occur as opportunistic infections. The criterion standard for diagnosing infection is the bacteriologic and/or serologic identification of causative organisms, but other auxiliary tests may be useful.
Bacterial Infection
Bacterial pneumonia is the most frequent infection in patients treated for RA and may be diagnosed with the tests for urine antigens of Streptococcus pneumonia and Legionella pneumophila. Imaging features of bacterial pneumonia include consolidation from lobular size to lobar distribution (Figure 8 [bacterial pneumonia]).
Mycobacterial Infection
Recently, the wide use of anticytokine biologic drugs has increased the risk of tuberculosis in patients with RA. Prophylactic administration of antituberculous drugs is recommended in patients at high risk for tuberculosis, such as those with pre-existing tuberculosis or diabetes mellitus or those who have undergone glucocorticoid treatment. Standard tests to identify Mycobacterium tuberculosis include acid-fast bacillus staining and/or polymerase chain reaction (PCR) for sputum or gastric juice. QuantiFERON (Cellestis Limited, Carnegie, Victoria, Australia) is a more sensitive and specific test to diagnose tuberculosis that can detect Mycobacterium tuberculosis infection more accurately than the tuberculin purified protein derivative skin test [8, 9] .
Imaging features of postprimary tuberculosis include a small, well-circumscribed, nodular opacity approximately 5e10 mm in diameter that typically shows centrilobular distribution. Large cavitary nodule and/or mass shadow or consolidation may be seen. Miliary tuberculosis involves the hematogenous spread of tuberculosis bacilli and appears as randomly distributed fine nodular opacities less than 2 mm in diameter ( Figure 9 [tuberculosis]; Figure 10 [miliary tuberculosis]). In patients with RA, airway injury and decreased immunity from treatment may cause vulnerability to nontuberculous mycobacteriosis. Imaging features may mimic tuberculosis or present nodular or patchy consolidation predominantly in the right middle lobe and left lingula. Administration of anticytokine biologic drugs may be restricted in cases with nontuberculous mycobacteriosis [10] .
Fungal Infection
Fungal infection, such as Aspergillus and Cryptococcus neoformans, is also seen in patients with RA. Invasive aspergillosis is rare in patients with RA. Structural distortion and decreased immunity from RA may increase the risk of chronic necrotizing aspergillosis ( Figure 11 [cryptococcosis]; Figure 12 [chronic necrotizing aspergillosis]).
PcP
One of the most common infections in patients with RA is PcP. The criterion standard for its diagnosis is appropriate staining to identify the organism in respiratory tract secretion. In most PcP in patients treated for RA, sputum shows positive PCR with negative staining of P jiroveci. Serum b-D glucan is a useful auxiliary test for PcP; with a cut-off level estimated at 31.1 pg/mL, sensitivity of 92%, and specificity of 86% [11] . Imaging features of PcP include GGO without structural distortion. GGO may show panlobular or multilobular distribution with sharp demarcation [12] (Figure 13 [PcP]).
Diagnosis Pitfall
In patients treated for RA, radiographic features of lung complications of acute or subacute onset often overlap. Especially, diffuse GGO is frequently seen in many diseases. Correct differential diagnosis requires knowledge of and attention to clinical and imaging features and exclusion of infection with laboratory tests (Figures 14e16) .
Conclusion
Although lung complications of acute or subacute onset in patients with RA are often difficult to diagnose, knowledge of their combined clinical signs and course, as well as laboratory and radiologic findings, is an important tool in assessing these patients. negative Pneumocystis polymerase chain reaction. First, we suspected bucillamine-induced lung injury. However, her symptoms and CT abnormalities did not improve despite cessation of bucillamine, so we thought acute exacerbation of usual (usual interstitial pneumonia) pattern was more likely than drug-induced lung injury.
